We are live on
!
Find out more
B
Bpifrance Portfolio holdings
AUM
$1.65B
1-Year Est. Return
19.85%
This Fund
S&P 500
This Quarter
Est. Return
+26.99%
1 Year Est. Return
-19.85%
3 Year Est. Return
-49.36%
5 Year Est. Return
-48.43%
10 Year Est. Return
–
AUM
$405M
AUM Growth
+$71.5M
(+21%)
Cap. Flow
+$2.52M
Cap. Flow
% of AUM
0.62%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
1
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SQNS
Sequans Communications SA
SQNS
|
+$2.42M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
+$212K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mitek Systems
MITK
|
+$115K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 41.77% |
| 2 | Materials | 31.05% |
| 3 | Technology | 19.01% |
| 4 | Communication Services | 7.64% |
| 5 | Healthcare | 0.52% |
Similar funds
CCM
BFPW
PP
ACM
NSIM
RIA
GACM
ELI
Bpifrance's Q2 2020 Portfolio in Review
As of Q2 2020, Bpifrance held 8 positions worth $405M, up 21% from $334M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Bpifrance's Q2 2020 filing shows 1 new, 1 increased and 1 closed positions. Its largest new stake was Crinetics Pharmaceuticals: 12,418 shares worth $218K. The largest sale was Mitek Systems, an estimated $115K.
By sector, the portfolio is most concentrated in Energy at 42% of assets, down from 51% a quarter earlier, followed by Materials and Technology.
- Bpifrance's largest Q2 2020 buy was Crinetics Pharmaceuticals: 12,418 shares worth $218K.
- Bpifrance added most to Sequans Communications SA in Q2 2020, an estimated $2.42M increase.
- Bpifrance fully exited Mitek Systems in Q2 2020, selling an estimated $115K.
- Bpifrance's ten largest holdings make up 100% of its $405M portfolio in Q2 2020.
- Bpifrance opened 1 new position and closed 1 in Q2 2020.
- Bpifrance's portfolio value rose 21% quarter-over-quarter to $405M.
Based on Bpifrance's 13F filing for Q2 2020, filed 31 Jul 2020.